Triple-negative breast cancer (TNBC) is any breast cancer that either lacks or shows low... the tumor is negative on all three tests giving the name triple-negative). [1] Triple-negative is...
Triple-negative breast cancer (TNBC) accounts for about 10-15% of all breast cancers. Learn more about triple-negative breast cancer here.
Triple-negative breast cancer is a rare type of breast cancer in which all receptor tests come back negative. It’s serious, but it responds well to treatment if you catch it early. Learn more about...
Breast cancers are ER-positive, HER2-positive, or triple negative. The type of breast cancer you have determines the type of medication you take. Learn more from experts at WebMD.
Aly Taylor was 24 and on the cusp of starting a family when she was diagnosed with stage III triple-negative breast cancer. After completing treatment at MD Anderson, Aly and her husband Josh were...
Triple-negative breast cancer is estrogen receptor-negative, progesterone receptor-negative, and HER2-negative. Learn more about how common it is and how it's typically treated.
Hormone receptors: estrogen and progesterone ; Your pathology report will include the results of a hormone receptor assay, a test that tells you whether or not the breast cancer cells have receptors for the hormones estrogen and progesterone. Hormone receptors are proteins — found in and on breast cells — that pick up signals from the hormones telling the cells to grow. A breast cancer is estrogen receptor-positive if it has receptors for estrogen. This suggests that the cancer cells, like n...
A credible source for triple negative breast cancer information, helpful resources and a caring community for TNBC patients and their families.
Until I was diagnosed with stage I triple-negative breast cancer in December 2016, I didn’t know much about immunotherapy. But as an executive assistant in MD Anderson’s Radiation Oncology department for more than 25 years, I’d heard the term used before by our doctors. I never thought that one day it would save my own life. When I started my treatment, I joined a clinical trial being conducted by MD Anderson’s Breast Cancer Moon Shot™ . The trial was unique because I was able to start...
Triple-negative breast cancer (TNBC) is a rare breast cancer that’s challenging to treat. Its cells don’t have the same receptors or proteins that help cancer grow.